Protein Intake on a GLP-1: Why It Matters More

GLP-1 drugs work largely by reducing appetite, and that’s the point. But the same effect that drives weight loss creates a quieter problem: when you eat far less overall, it’s easy to under-eat protein specifically. And protein is the nutrient that does the most to protect muscle during weight loss. On these drugs, getting enough of it shifts from generally good advice to something closer to essential.

This is one of the clearer cases where a well-supported nutrition principle becomes more important, not because the science changed, but because the context did.

Why weight loss puts muscle at risk

Any substantial weight loss, by any method, includes some loss of lean mass alongside fat. That’s not unique to GLP-1 drugs, but the drugs have now quantified it. A body-composition substudy of the STEP 1 trial (140 participants, Journal of the Endocrine Society, 2021) used DEXA scanning and found that of the 15% total weight lost on semaglutide, lean body mass fell about 9.7% — roughly a third to 40% of the weight lost came from lean tissue rather than fat. Notably, lean mass as a proportion of total body mass actually rose, because fat fell faster. Still, the absolute lean-mass loss is real, and it scales with how much weight comes off.

Muscle isn’t just about strength or appearance. It’s metabolically important and strongly associated with healthy aging, mobility, and metabolic health. Losing a large fraction of weight as muscle is a worse outcome than losing it as fat, even at the same number on the scale.

The honest core: in STEP 1’s DEXA substudy, a substantial share — roughly a third to 40% — of weight lost was lean mass. The question isn’t whether to prevent it entirely but how much you can blunt it. Adequate protein and resistance training are the two best-supported levers, and on a GLP-1 they matter more because intake drops so sharply.

The two levers that actually help

The evidence consistently points to two interventions that reduce muscle loss during weight loss:

• Sufficient dietary protein, which supports muscle protein synthesis and helps preserve lean mass in a calorie deficit.
• Resistance training, which provides the stimulus that tells the body to keep muscle.

Neither is novel. Both are simply harder to get right when appetite is suppressed, because you’re working with a smaller total intake and have to be deliberate about how it’s allocated.

Targets and how to think about them

General guidance for preserving muscle during weight loss tends to favor protein intakes well above the basic minimum (the RDA is just 0.8 g/kg/day). For people on anti-obesity medications, the American Society for Metabolic and Bariatric Surgery’s 2024 guidance suggests roughly 1.2–1.5 g of protein per kilogram of ideal body weight per day. Exact numbers vary by source and individual, and this isn’t medical advice, but the direction is consistent: aim well above the default minimum, and prioritize protein within a reduced appetite.

Practical framing that comes up repeatedly:

• Treat protein as the first thing the meal is built around, not the leftover.
• Spread it across meals rather than loading it all at once.
• Lean toward protein-dense foods, since total food volume is limited by reduced appetite.

The point isn’t a magic number. It’s that when you’re eating less, the margin for under-shooting protein shrinks, so deliberate prioritization matters more.

A measured read

None of this is exotic, and that’s worth saying plainly. The protein-and-resistance-training combination for preserving muscle during weight loss is one of the better-established ideas in nutrition. GLP-1 drugs don’t change that science; they raise the stakes of getting it right by making under-eating so easy. The honest limit is that exact targets are debated and individual, but the principle is robust.

The takeaway

On a GLP-1, protein matters more because appetite suppression makes it easy to under-eat the very nutrient that protects muscle during weight loss — and DEXA data shows a meaningful slice of that loss is lean tissue. The well-supported strategy, ample protein plus resistance training, doesn’t change; the context makes it more consequential. Prioritize protein deliberately, train against resistance, and treat lean-mass preservation as part of the goal, not an afterthought to the number on the scale.

Sources

• Wilding JPH et al. Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study. Journal of the Endocrine Society, 2021
• GLP-1 drugs and muscle loss: what the data says about preserving lean mass (review of protein/resistance-training evidence)